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Coronary res,ewd\ remains a majnr problem for interventional 
cardioln~ no, only by virtue of its frequency. but also because of 
lbe cuwent inabilll) lo prevrnl it. Symplomatic status and non. 
invasive evaluation baw been wed to stud) res,enolis, bu, both 
lrck vpeeiacilv and senlltivilv, par,icu,ar,g in patients with mul. 
angiographic twhniquer. In anolhor appmach, linear modeling is 
used to asw minimal luminal diameter al lesions on restudy. 
Although angiographic studies have been essential in tbe study 
ofrrslmoris, questions wncerning the underlying mlebanism and 
palbophyniology rrmuin. The develapmmtt of animal models that 
closely resemble human restenosir should allow evaluation of 
pnthophynioloaic mechanisms and dovclopmem of new skatebief 
to prewd Ihe problem. 
(J Am Coil Cardial 1991:17:14E228) 
Coronary re*teno,is has been called the Achilles heel of 
d&lion no, only by virtue of its frequency. but also because 
ofour inability ,o prevent i,: if remains the major obslacle 10 
Ideal lasting coronary angiaplastg resuh~ (I-81. Because 
primary success xtc\ iwc improved and complications 
have decrcascd. rotenosis has come to occupy a central role 
in mterveniwnal cardiulogy. Although angioplasty was ini- 
tially portul@ed 10 be a less expensive alternalive ,o surgical 
revaxulariralion. Ihc co>, of evaluation and treatment of 
retleno+ neu,ralizes many of ,he po,cn,ial cos, savings 
~9.10,. Of eaual impor,aoce ha, been the osvcholoaic imDor- 
tance to boih pali& and referring phy;i& when rymp- 
loon identical to lhoae that led 10 Ihc initial evaluation recur 
soon after Ireatmen,. When re>le”ob,, ,s cvcntually pre- 
vented. the number of patients who wdl undergo angiopla~ty 
will increase. 
Noninvasive Evaluation 
Predictive value of symptom recurrences. There are many 
polential means of rludying coronary reslenusis. For the 
patient. recurrcnc’: of rymptoms is a hallmark of restenosix 
Exercise-induced ischemia. eilher silent or symptomatic. is 
also an indica\or. The use of either of ,hese end poinls lo 
rludy re~teno ,JS ,$ problematic. Although symptom rccur- 
rence i\ often ass&&d wilh res,eno& in patienls with 
single vc& disease. in come palien, despile recurrent 
symp,oms. ,he previously dilated artery is widely patenl 
without aignifican, restenosis. In some of these palients. the 
recurrem symp,ams may be related to vssospasm or a 
sulwplimal initial result. The problem is somewhat more 
difficult in palients who have multivessel disease in whom 
continued or recurrent symptoms may be related 10 undi- 
la,ed stenoses or progression of disease in other vessels. 
Informalion as 10 how often angina is present after dilation in 
the absence of angiographic restenosis is difficult to assess. 
In the National Hear,. Lung. and Blood Institute Percutane- 
OUT Transluminal Coronary Angioplasty Registry (I I). 44% 
of patixs with definite or orobabk angina during follow-uo 
s&y did not have resten& al the t&of angio&hy (Fig. 
Il. Among several series (U-16). the positive predictive 
value of rymploms for predicting restenosis ranged fmm 
44% 10 9255 112-16). Symp,om recurrence also lacks speci- 
fici,y. This is not surprising. given the number of potential 
causes of angina. including a suboptimal initial result. vaso- 
spasm (17). incomplcle revascularizatian, disease progres- 
sion and noncardiac chest pain. 
Role of noninvasive stress kstine. Functional testing afler 
dilalion also presenls problems. if ,he pa,ient is &mpto- 
malic. ,he meaning of an abnormal functional test resull is 
not clear-i, may relale lo an inadequate inidal dila,ion or to 
restenosis that is no, yet severe enough 10 be symptomalic. 
The problem is somewhat more difficult in patients currently 
being trea,ed with angioplasly. many of whom have multi- 
vessel disease. In these oalienls. an abnormal lest result 
could be caused by undilsted lesions or progression of 
digease. Treadmill exercise testing. exercise thallium scin- 
ligraphy. radionuclide angiography and dipyridamole echo- 
cardiography have all been used to predict restenosis (IS- 
31). In treadmill testing. exercise-induced angina is a better 
predictor than is ST segment depression (32). The positive 
predictive value of radionuclide angiography and roam- 
graphic thallium scintigraphy in combination i\ better than 
that of exerciv testing alone l18.19.?3.??-IK3!~. Wth holh 
mdionuclidc angiogrophy and lhellium ximigraphy. :hc ncp 
ative predictive value is usually bcttcr than the povtive 
predictive value. Even with thebe \todic\. ~uw:wnent of the 
frequency of restenosis in a specific potwnt ,uh\et. particu- 
larly those with multivessel direabe. ir difficult. 
The ohwnce of porivnr ~yo~prom~ has hcnr n.wd II> II 
srnro~otc for ~~sses~nw~~t of rccrrcvw~ir Although from the 
patient’s point ofview this mny be lhe gwl. from ii xicntific 
standpoint this is a Rawed evaluation tcchmque. Begmnmg 
with the initiel Natiocal Heart. Lung. and Blood lnstm~tc 
coronary angioplasty r&try (I I). o \\a\ recogwed that 
approximately 25% of patients with re\tenori\ arc a\ympw 
matic (Fig. I). Thus. for the porpo\e of studying the problem 
or phenomenon of restenosis. reliance on \ymptomatac cri- 
teria or even fuwtional testing: is not wt&ctory. 
Role of Angiography 
Because no noninvaGve ut yet employed h;n Ideal 
sensitivity and specificity. coronary anpiography rcmaim Ihe 
reference slandard for the wdy of re\lenoG’i. In \todying 
the restenosis phenomenon. patient wlection for iollou-up 
angiogwphy is of major importance. If more symptomatic 
than asymptomatic patients undergo followup anpiography. 
restenosir rate\ will be artificudly high hecauw the frr- 
quency of restenorn will he higher in the forma groop than 
in the latter. Study of Ihe frequency and timing uf rcano% 
requires that there be a hagh law ofangwsraphic follow-up of 
patientc. The timing of followup angiupnrphy I\ zdw impor- 
Pant. particularly if only one f~~llou-up study i> to be pcr- 
formed. Depending on when re~tenoris UCCUI\. wrly fol- 
lowup anpiography mav mns restrnori\. 
Definition of Restenosis 
Definilions. Although angiography remains the reference 
\t;lnd’vd for identifying rc~tcno~i~. the detinmon ofresleno- 
\I\ I\ conlrover~ial. All of the definitions are arbitrary- 
mdny hwe hecn wed (Table I) 1?.4.11.3.~45). Some of the 
a~w~~rnen~\ have been made wing visual e%imate9 of the 
coronw~ woosis: others heve employed quantitative ang~- 
ograph?. In [he initial National Heat. Lung and Blood 
InQdutc angmplnsly re$istrg I I Il. fox arbitrary definitnts 
acre \tudled: I) an increase 230% from the immediate 
poUang~opl;~~ty stenosir to the follow-up stenosis: ?) an 
iniuol <Wi *tenosi\ afterangioplasty that increased to 70% 
at folloa-up angiogmphy 3) an increase in stenosis at 
fXowup .mpiapraphy up to 210% below the predilation 
\tenw\: and 41 a lobs of zW% of the initial gain achieved by 
angioplaty. Although there WI\ wb\tantial overlap of the 
definmon\. not all patients included in one definition were 
included m other definitmns. A Venn diagram waz initially 
wlectcd to dlustrt~te this overlap. Thir same dmgmmmatic 
formu ha* been ored in sub*cqucnt wries to emphasize the 
pant (Fug. 21. Another commonly used definition ix an 
immediate pwt-angiaplartg ctenosis of <SW that increases 
IO >iO% ot the time of follw-up angiognphy. Any of these 
definmon\ nhen token to their cxtremcs may be flawed; for 
cumple. with the lalterdefinition. a 45% lesion immediately 
after dllatlon may increase to a 55% lesion and meet the 
dichotomous overall criterion of reslenoris without having 
any mmningfot importance. 
Qoantitntivr angiiographie aswsmenl. Optimal assess- 
ment ,hould he performed by a panel without a vested 
interest in the outcome of the procedure (46.47): the inter- 
r~entional cardiologist performing the dilation tends to over- 
e\tim;itc the severity of the stenosis before dilation and to 
undere\timare the stenosis aftcr nngioplasty. Consensus 
viwal a~~ewneot by a panel of experienced angiographers 
uung uandard technique% and identncnl side by side projec- 
tor\ oHen rhe best approach to vtsual ave~sroeot for re- 
*arch porpmes. Although very were lesions and minimal 
lesiunr con usually be accurately awessed. ~tenoses in the 
20% to 70% range are the most difficult (48). Many patients 
are in thn latter group nnmediarely after coronary angio- 
plasty. In this wtting. there hai been lack of correlalion 
between stenosis wwity and mwsures of coronary perfu- 
?ion. For lhls reaton. quanlitawe angiagraphic techniques 
have been employed, rangmg from calibraled reticleb on 
large prints of cinc film wdh electronic caliper, to operator- 
inleracwe or auttimated edge detecuon systems for geomet- 
ric and .ideodcnsiromctric stenosis airing (X.36.39. 
40.42.431. When these techniques have beer, employed and 
compared with visual eslimaler. quudilolive methods con- 
sistently assess stenoses to be less severe than do visual 
eslinws (1.36.39.42l. For this reason. definitions of re- 
stenosis employing vtsual percent stenosis measurements 
cannot be directly related to quanlitalive ar.%ssmem using 
the manic definilion- 
Newer definidons of rwemwis. Mare recenrly. quantita- 
tive angiography that provides an absolute measurement of 
IcGon dimension- has been used to develop new definitions 
of restenosis. Assessment of the changes in minimal lummal 
diameter that occur after dilation has been suggested. Pre- 
vious investiRalors (36.43) defined reslenosir as a decrease in 
minimal lu&al diameter ~0.72 mm compared with the 
posrangioplasty result. This number was based on the rtan- 
dard deviation of repeal angiogrnphic measurements in 26 
patients who had IWO angiograms before angioplasty (43). In 
the 26 patients initially studied. the long-term variability in 
the minimal luminal diameter was 0.36 mm. (This number 
may be critically dependent on the syslem used for imaging 
and rigid protocols for image recording. Given the variability 
among laboratorier as well as technical variahilily. such 
precision is unlikely to be widely achievable.) Irrespective of 
iha!. 2 SD (2 x 0.36 = 0.72 mm) was used as a definition of 
B ~ignificanl change in the lesion under study (43). This 
number (0.72 mm) was then used as the arbitrary boundary 
for defining a significant change Irestenosis). 
Ouantilalive definitions includine the lesion minimal Iu- 
minal diameter also avoid problems~n assessing the adjacent 
“normal” vessel. Hislopalhologic studies (44) have docu- 
mented that the extent of coronary artery disease is fre- 
quently underestimated by angiography. In addition. the 
adiacenl “reference” diameters have been shown (44) to 
de&ease from immrdi.+Ielv after angioplasty to repeat angi- 
ography 3 or 4 months later. This reduction may occur 
because the adjacent vessel is dilated at the time of angio- 
plarty. The change in reference diameter may be up lo half 
Ihe mean reduction in lesion minimal luminal diameter. 
Nobuyoshi et al. 05) also reported on serial angiogmphic 
studier. Cine videodensilometry was used. with rertenosis 
defined a\ >50% ,053 of the gain in the absolute steno- 
sis diameter. In a smdll subset of their patients. serial 
angiograms were performed before angioplasty. A change 
>OSO mm was regarded as signilicard. When these defini- 
tions are used, considerable overlap exists wilh other more 
conventional definitions. Although these newer definitions 
may be less subjecdve and more reproducible, they do not 
solve all the problems of angiographic evaluation. For high 
qualily dedicated lahoralorier with !ho ::sowces and per- 
sonnel for dwlal assessment of results. these values may he 
quite reproducible. ahhough even in lhis selling there are 
problems. Afler dilation. the dilated segmenl is often hazy. 
wiih indistinct edges. flaps or dissections. In the latler 
setting. determining. what represents the lumen may be 
diffxult, so that a good baseline stenosis for comparison wth 
subsequent angiogmma may not be available (Fig. 3). There 
is also the problem of eccentric lesions. Some of these 
lesions can be accunlely assessed with orthogonal views. 
whereas others may not. Finally. lhere is the problem of 
identifying a “normal segment” for comparison if percent 
diameter changes are used. 
Videodenriiometric methods have also been uxd for 
assessment of restenosis (491. Identifying the oplimal equip- 
ment and melhoda cominues to generate considerable con- 
troversy. Although widely used. quantitative angiography 
has not been found in any study to be superior to viwl 
estimates in predicting specific or even general group alwnt 
outcome. As a resuh of these mcawrement and definition 
problems even with quanlitdtivc anpiugrephy. other rech- 
niques have been intensively wdied. including meav~rc- 
ment~ of coronary Row or Row rc\cr~c. coronilry hlosd 
velwily. impedance and indicator-ddulion prmciolcr ISO- 
52): none have found widehpreud applicahilily and none are 
used rourinely. Whether inlrovaxohrr ultr;nound o: anpov 
copy will have nn impacl m thn regard remtint to he \ludicd. 
Conclusion. Despite the problems in dctinninn and meth- 
ods used for dckrmining re\tenos~*. coronar) angio@r;tphy i\ 
,he ccnlral focu, of a\\e,\ment of rc\tcno\,\ and i, the 
primary end point in trial\ ued IO awz~\ rhe unpact of new 
therapies on re,,enoa,, ri,te\. Angwgaphy plays an es\eolial 
role in defininp !hc liming and incidence of re~!eno&. After 
the incidence of rcwnosk i\ documented. clinicai. angio- 
gtxphic and procedual var!ahle, can then be evaluakd for 
significant relarions. Such a\wciztion\ zdlo* the powbdlly 
of uncovering a~clal~on\ imd potentially providing a clue 
it> to mechanivn*. 
Timing of Restenosis 
Earl> coronary reslenosis. Angiographic studin 13.11.33- 
37) have allowed phykiam to wdy the timmg of reQeno- 
sis. For Ihi\. wr~l long~~udoxal angiogmphic >tudica are 
optimal. In Ihe inilial National Hurt. Lung. and Blood 
Imtilute anf~oplarly rcgktry C I I ). there wab a strong relarion 
:onon,ne *ymplom recurrence. :he need and timing of angiog- 
raphy and rew~osn. The incidence of recrenosis m parienrs 
who undcrwnt anplography was highest within the 1st 5 
monrh~ after angioplasty (Fig. 4). This finding has been 
amply cuh*lanliared in whsequenl studies II 1.33-371. In a 
reric~ of 9% patients undergoing follow-up angiography. 
Lelmgrsher el al. I331 found that the higbesl rate of resteoo- 
si\ ua\ observed in palienrs undergoing Ihe procedure 
during Ihe 1st 4 months after angioplasry. These early 
\tudle\ uwally involved only one follow-up angiogram. 
Bcca~x of selecdon bias. tr,<y provide more mfommtian 
ahout symptomatic than about silent ischemia. These results 
have been wbstantiated by the results of studies f20.?1.24- 
?7.311 uung noninvasive techniques (treadmill exercise test- 
ing. mddionuclide angiography and thallium scidigraphy) that 
hw qhoun that abnormal functional tests occur “early” 
and are associated with an increased incidence of rcstenacis. 
Serial sngio-graphie evaluation. TWO important studies 
135.36) have utilized serial longitudinal angiographic evalua- 
tion. These have the advantage of excluding patient selection 
months rnw re,teno& had accurrcd. NHLBl = Nadonal Heart. 
Lunp. and Blood Institute. Heproduced from Serrugs et al. I361 wilh 
per miwi011 af Ihe Amer~an Hean Axxiation. Inc. 
bias for angiogrdphic iollow-up study. Nobuyoshi et al. (35) 
performed serial angiognms in 229 patients at 1.3.6 and I2 
monthrafter ,ucccs,fid angioplasty. Although sornc rcstcna- 
sis was documented at I month (II%). the majority of 
previourly reported series of paticnls with a high rate of 
angiographic follow-up. In such series (I 1.33-37). the re- 
stenosis rate has been approximately 30% to 40%. 
Restenosis in specific patient subsets. Although past eon- 
ventional wisdom has been that restenosis oeeors in 25% to 
30% of patiems undergoing dilation. in specific patient 
subsets and padents currently undergoing dilation. the rate 
may be romcwhat higher 154-57). In the series oiNobuyosbi 
et al. (35). the rcstenosis rate at 3, 6 and I2 montha was 
39.2 i 5.7% 44.8 + 5.8% and 47.6 r 6.0%. respectively. In 
patients with single vessel disease. the restenosis rate at 6 
months was 48%. similar to that seen in patients with 
multivessel disease (47.6 + 9.6%). In the scrici reported by 
Scrruvs et al. 1361. the incidence of rcstenosis at 4 monms 
was 23% and was still increasing. In a randomized study of 
anticlatelct theraov from the Maw Clinic (581. the rcstcnosis 
rate: defined as i&s of ~50% of the postangioplasty gain, 
was 46% as assessed by quantitative angiography. There arc 
several potential reasons for this increase in the rate of 
restenosis. In these series. the angiographic follow-up rate 
was excellent. An equally important reason may be a differ- 
ence in patient groups undergoing dilation. Patients with 
more unstable angina. total coronary occlusions and corn- 
plex anatomy are included in eurrcnt series; these factors 
ratenoses occurred within 3 months. From 3 to 6 months. have been associated with increased rcstettosis. 
there was onlv a small increase in the rcstenosis rate 139.2 i lmolications for rtcw tcehnolwv. Documentation of this 
5.7% to 44.8 & 5.8%). with an addi:ional small increment to ittcre&d incidence of restettosis~ks impatant implications 
47.6 + 6.0% at I year. As previously mentioned. Serruys et for new technology. If a new technology is found to be 
al. 06) performed repeat angiography in 342 paliems. 93 of associated with a 4S% resrenosis rate. one could mistakerdy 
whom had an$iography at I month, 79 at 2 months. 82 at 3 believe that this restcnosis rate is higher than the convcn- 
months and 88 at 4 months. In this study. the time course of tionrd value of a 30% incidence rate of rcstcnosis with 
rcstenosis varied depending on the definition used. For each dilation. whereas in fact the rates may be identical. This 
definition. the majority of eases of restenosis occurred by 3 possibility underscores the need for randomized trials to 
month3 (Fig. 51. compare differing technology in terms of restenosis. 
The tindine that most restenosis is seen within 6 months 
has been the-basis ior subsequent studies evaluating new lrimed sr wd;r& resrmosis has been lkar modeling to 
techniques and strategies. These new studies (for example. predict the minimal luminal diameter of a lesion on restudy 
the use of atherectomy and laser angioplasty) usually involve after dilation. Patient and lesion variables (including the 
a 6 month follow-up aneiwram. Althoueh most rcstenosis minimal luminal diameter before and immediatelv after dila- 
Afrorhtr n~oroach 10 the annlvsir of clinical srudies 
occors within the Isi 4 to6 months. later &tenosis has been tion) are both incorporated into the model. II &at then be 
documented (53). determined whether therapy with the study medication, 
which is also included in the model, predicts increased 
Incidence of Restenosis 
minimal luminal diameter on restudy. This method avoids 
arbitrary definitions of rertenasis, increases the power of the 
The definition oirestenosis used has the greatest effect on study to detect a treatment effect and permits asscssmcnt of 
the incidence of rester&s. In addition, the tvpc of patient other factors txdentiallv influencitw rcstenosis. 
studied may have a sobstantial impact on this incidence. 
Because the type of patient undergoing dilation has changed. 
restenosis rates may also be changing in accordance with Associated Clinical and Anglographic Factors 
Bayer’ theorem. This relates to the fact that the frequency of lo addition to helping define the timing and incidence oi 
patient characteristics associated with mcrcased restenosis restenosis. angiographic studies have allowed study of clin- 
rates is increasing in patients concurrcndy undergoing dila- ical. angiographic and dilation factors associated with in- 
tion. For example. the proportion of patients with multives- creased restcnosis r&s. From the an&graphic studies 
sel disease. chronic occlusion and unstable angina is higher considered together (I 1.33-38.59-71). there arc several 
in current (54-57) than in older dilation series. Despite these groups of patients in whom rcstcnosis rates are definitely 
factors. there has been a surprising degree of consistency in increased. Related clinical factors include male gender, 
Figure 6. Diagrammatic representation f the ef. 
feel ofinhial and Soal stenLwis rares on restenosis 
rates. For therapy asraeiated wth a very cmall 
residual (<IO%1 Stemxis (for example. adxrec- 
tomyh rcstcnosis may OCEUT. but Ike parienr may 
srill have a hemodynamiealty inrigniRcant lesion. 
For therapy that leaves a more severe residual 
stenosis (for exampie. a stand-alone laser pmce- 
durc,. a more minor change in steno~s a, follow-up 
angiocraphy may result in a significant (tenoris. 
MCA = percutaneous transluminal coronary angi- 
omaphy. Modified from CaliR et al. (161. 
unstable angina. vasospastic angina and prior dilation of the 
scgmenr. Angiographic factors include jwoximal left anterior 
descending coronary artery disease. vein graft aortic or vein 
graft body stenosis. left main coronary artery stenosis. 
dilation of multiple lesions and chronic occlusions. Finally. 
dilation variables include a suboptimal final result or a large 
dissection. Knowledge of these factors allows lhe primary 
physician and interventional cardiologist to formulate the 
optimal treatment program. It must bc remembered that for 
the individual patient, statistics may not be meaningful for 
discrete ootcome variables. 
Evaluation of Prevention Strategies 
Angiographic findings have been used as the primary end 
point in trials of medication and strategies aimed at prevent- 
ing rcstcnosia. Numerous approaches have been tested, 
including antiplatelet regimens, Coumadin Iwarfarinl. corti- 
costeroids, colchicinc. calcium channel antagonists, hep 
arin, thmmboxane A, inhibitors and pros:acyclins l58.72- 
80). None have been found to be effective in preventing 
restenosis. Afler an initial flurry of cothusiacm for n-3 farty 
acids, subsequent studies 181-84) found this approach incf- 
fective. In all of these studies. quantitative angiography is 
essential in documenting etlicacy. 
New Devices 
Angiography plays as essential a role in evaluating new 
devices such as atherectomy. stents and lasers as il does in 
evaluating conventional dilalion. The importance of angiog 
mphy is related lo a similar lack of correlation of symptom 
s&s with the aogiographic findings. The definition of 
restenosis may be more difficult with these new devices 
because the residual stenosis may be quite di&rent from 
that seen wbh conventiooal dilation. Califl et at. 116) dia- 
grammatically illustrated the relation belween the definition 
of restenosi? used. the relative SUEC~ES of Ihe procedure and 
the incidence of restenosis. Given that these new devices 
may have greater variability and perhaps systematic variabil- 
ity of Ihe postintervention residual stenosis, the definition of 
rcsteno~s may become more of a problem. 
Alhereetomy. The Atherotarh was recently approved fur 
coronary artery ore (85). The initial application will be in the 
proximal coronary aneries and vein grafts. With this device. 
success rates ldelincd BE removal of tissue and a residual 
stenosis <507e) of 85% to 901c have been reported (85). 
TypiCally after atherectomy. the residual lumen by angio- 
graphic appearance is smoother and Lhe stenosis lcs~ severe 
(approximately IO% to 20%) compared with that after con- 
v&tional dilation. The definition of restecasis will have a 
significant impact on the measured rate ofrestetmsir (86). As 
illu~wated in Figure 6. ifthe initial result reduces the stenosis 
from 90% 1o 6% or IO% after athercctomy, loss of 50% of rhe 
gain would result in a stenosis of 40% at 6 months. This 
lesion would still be associated with an excellent sympto- 
matic outcome. but would nonetheless bc classified as re- 
stenosis. 
Laser angio+ty. For coronary artery laser treatmcot, 
the problem may be worse. A high rate of rertewris has 
been reported (87) when a laser technique is combined with 
dilation. This has led man) investigators to rely on laser 
treatment alone. With the current Excimcr laser devices. the 
largest Rbcrs in use are 2.2 mm. Because the Excimer laser 
is a contact ablative system. the residual stenosis will be no 
larger and is often somewhat smaller than the fiber size. If 
this system is used in larger vessek. the residual stenosis 
may remain significant. For a 4 mm vessel. Ihe residual 
stenosi? will remain SO’Z irrespective of the initial vessel relevance to tiwe obtained from atherectomy of restenotic 
stenosis: it will then take a relattvely minor increase in lesions in human patients. The pig is a more appropriate 
steno+ to make it significant again. With larger fibers. this animal model for studies of atherosclerosis and restenosis 
should be less of a problem. Currently. the most commonly because it is omnivorous. develops spontaneous atbrroscle- 
used laser definition of restenosis is a residual stenosis <SO% msis (without cholesterol feeding) and has a platelet coagu- 
and a follow-up angiographic residual stenosis ~50%. Quan- lation system similar to that of humans. Studies PXI) of 
titative measurements of lesion minimal luminal diameter are balloon dilation in the porcine carotid artery have demon- 
orobablv more a~t~ro~r~ate. strated the natural history of acute platelet, thrombus and 
Comparative restenosis rates. There are no comparative 
Intraroronilry’;tfnta. For intracoronary rtents. restertO_ 
s/s rates arc aI50 affected by the definition used. After 
stcnting. the residual stenosis is usually very small. often 
data on restenosis rates among the new devices. Although 
5 IoTn. Them can be a substantial increase in the stenosis 
before a 50% restenosis is reached. It is possible that a 
each new device has selected its own definition of restenosis. 
patient could have restenosis after stenting and yet have a 
smaller percent diameter stenosts than immediately after a 
further methodolocic study is resuired. Trulv comoarative 
successful stand alone laser procedure. For stents. the most 
common definition of restenosis, a follow-up stenosis >50%. 
is required. Although an increase in stenosis during fol- 
low-up angiography is not uncommon. it may not reach 
clinical significance. For these new devices. differentiation 
ofangiographic versus clmical restenosis will be increasingly 
important. 
subsequent intimal thickening. Recently, another porcine 
model (91) using the coronary arteries has been described 
with significant idvantages. This model involves deep arte- 
rial injury by means of metallic coil implantation in the 
coronary artery. This reliably induces a histopathologic 
resoonse identical to the nroliferative component of human 
&enoses seen in specimens obtained with atherectomy. 
This model has the potential to evaluate underlying patho- 
physiologic mechanisms. test new strategies to prevent 
restenosis and provide a comparison with angiographic 
TCBUbE. 
Conclusions 
data will come o&from random&d studies df p&ots who 
could be treated with either technique. Because patient and 
angiographic characteristics may affect restenosis rates. 
objervational stildies will not be sufficient. If. for instance. 
only high risk lesions are treated with one new device and 
lesions that could easily have been dilated are treated with a 
different new device, comparison of restenosis rates be- 
tween these two devices will be meaningless. 
ography using linear modeling to predict l&m dimensions 
at restudy will be a valuable tool in the study of restenosia. 
Coronary angiography is an essential tool for the ev6lua- 
Although angiography is essential for stud$ng restenosis, 
tion of restenosis. It has allowed characterization of the 
clinical symptoms or clinical restenosis is more important to 
the patient. Patients with a mild degree of restenosis may 
lesions. time course and incidence. Currently, the definition 
have minimal or even no symptoms. Finally. despite the 
value of angiography. it cannot completely address the 
of restenosis is a dichotomous variable. Quantitative angi- 
pathophysiology of the rester&s phenomenon. For this. 
new technologies and models are required. 
Limitations of Coronary Angiography 
Although angiographic studies have been essential in the 
study of the timmg and incidence of restenosis, they have 
not provided information on the underlying mechanism or 
pathophysiology. Given the several potential factors (name- 
ly. platelets, smooth muscle cells. ground substance or a 
combination of all of these) that could he involved in 
restenosis. angiography cannot distinguish among them. 
Some of the new procedures (for example, atherectomy) that 
allow for histopathologic assessment have been extremely 
helpful in this regard. Other new imaging techniques (for 
example. intravascular ultrasound or angioscopy) may be 
helpful. Even more important will be the development of 
animal models that closely resemble human restenosis. 
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